This paper is in the following e-collection/theme issue:

Systematic Review Protocols (244) Pediatrics (185) Gastroenterology and Hepatology (53)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46375, first published .
Pediatric Tui Na for Feeding Intolerance in Premature Infants: Protocol for a Systematic Review and Meta-Analysis

Pediatric Tui Na for Feeding Intolerance in Premature Infants: Protocol for a Systematic Review and Meta-Analysis

Pediatric Tui Na for Feeding Intolerance in Premature Infants: Protocol for a Systematic Review and Meta-Analysis

Authors of this article:

Zirong Bai1, 2 Author Orcid Image ;   Xiaoxiao Lyu3 Author Orcid Image ;   Yichuan Tang1, 4 Author Orcid Image ;   Meng Wang1 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics

    Protocol

    1Department of Rehabilitation, College of Acupuncture and Moxibustion and Massage Health Preservation and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing, China

    2Department of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia

    3Department of Rehabilitation, Second People's Hospital of Tibet Autonomous Region, Tibet Autonomous Region, China

    4Faculty of Medicine and Health, School of Health Sciences, University of Sydney, Sydney, Australia

    Corresponding Author:

    Meng Wang, MD

    Department of Rehabilitation

    College of Acupuncture and Moxibustion and Massage Health Preservation and Rehabilitation

    Nanjing University of Chinese Medicine

    138 Xianlin Avenue

    Qixia District, Jiangsu Province

    Nanjing, 210023

    China

    Phone: 86 15077855256

    Email: wm4212576@163.com


    Background: Feeding intolerance (FI), frequently resulting from gastrointestinal immaturity, is prevalent among premature infants. Current practices are gradually prioritizing nonpharmacological treatments, such as massage or “Tui na,” considering the potential side effects of prolonged medication use. Pediatric Tui na, a specialized massage therapy based on traditional Chinese medicine, has been widely studied for treating FI in premature infants. However, to our knowledge, no systematic review specifically focusing on the effectiveness and safety of traditional Chinese medicine–based pediatric Tui na for FI in premature infants has been published yet.

    Objective: This study aims to develop a protocol for a systematic review and meta-analysis for evaluating the safety and efficacy of pediatric Tui na for premature infants with FI.

    Methods: We will perform a comprehensive search in the following databases: Springer, Cochrane Library, Embase, MEDLINE, Clarivate Analytics, Physiotherapy Evidence Database (PEDro), CINAHL, PubMed, Scopus, World Health Organization (WHO) International Clinical Trials Registry Platform, and Chinese biomedical databases (Wanfang database, the China National Knowledge Infrastructure, Chinese Scientific Journals Database, and Chinese Biomedical Literature Databases), limited to studies published in Chinese and English languages between January 2000 and January 2023. The search strategy will use MeSH (Medical Subject Headings) terms and database-specific keywords. A total of 2 independent reviewers will initially screen the studies based on titles and abstracts, followed by a full-text evaluation of the eligible studies. Studies will include any nonrandomized controlled trials, nonrandomized clinical studies, randomized controlled trials, and quasi-experimental studies wherein the treatment group involves premature infants with FI given pediatric Tui na. Primary outcomes will be necrotizing enterocolitis, gastric residual volume, emesis, and stool blood. Secondary outcomes will be abdominal distension weight gain, time to achieve full enteral feeding, any adverse effects associated with pediatric Tui na, and length of hospital stay. The Cochrane Collaboration Risk of Bias Tool will be used to assess the risk of bias and methodological quality. Funnel plots will be used for evaluating publication bias. Meta-analysis will be conducted using the Review Manager software (version 5.4; Cochrane Collaboration). Subgroup analyses will be considered according to treatment received, country or setting, sex, and birth weight of premature infants (if heterogeneity is high, I2≥50%).

    Results: This is a systematic review and meta-analysis protocol, so the results are not yet available. The protocol has been registered with PROSPERO (CRD42023390021). We are currently in the study selection phase. Results are expected to be completed by the end of 2023.

    Conclusions: Following this protocol, a comprehensive and rigorous literature synthesis will be developed to assess the impact of pediatric Tui na treatment on premature infants with FI, enabling the determination of its efficacy and safety.

    Trial Registration: PROSPERO CRD42023390021; https://tinyurl.com/bdf4kn23

    International Registered Report Identifier (IRRID): PRR1-10.2196/46375

    JMIR Res Protoc 2023;12:e46375

    doi:10.2196/46375

    Keywords

    feeding intolerance; pediatric tui na; premature infants; protocol; systematic review 


    Feeding intolerance (FI) is usually a consequence of gastrointestinal immaturity and commonly occurs in premature infants [1]. It typically presents as increased gastric residual volume (GRV), abdominal distention, vomiting, stool blood, and emesis [2], affecting 33.8%-53.45% of premature infants in China [3]. Furthermore, there is an association between high GRV and increased morbidity of necrotizing enterocolitis (NEC) [4,5]. These gastrointestinal immaturity–associated intestinal system problems can affect the nutritional intake and gut morbidity of premature infants, leading to several complications such as prolonged hospitalization and weight loss, and even increased mortality [6,7], thus placing a heavy burden on health care services.

    There is no ideal or effective treatment available for FI as its pathobiology remains to be fully understood and identified [8-10]. Previous guidelines and studies have primarily focused on pharmacotherapies for managing FI [11]. However, long-term use of medications such as erythromycin, probiotics, metoclopramide, and cisapride has been reported to be associated with many adverse effects (AEs), including neurological disorders and cardiovascular dysfunction [12-16], leading to a greater expenditure of time and money and posing a significant burden on patients [10]. Consequently, current guidelines and practices increasingly focus on nonpharmacological treatments such as massage or Tui na [4,17]. Pediatric Tui na, based on the principles of the meridian theory [18] of traditional Chinese medicine (TCM) [19], is widely used as a complementary and alternative medicine in East Asia [20-23]. It treats a range of pediatric diseases by applying various manipulations on the body surface, including pressing, kneading, circling, nipping, and pushing [24,25]. Studies have indicated that Tui na and other similar touch therapies can regulate hormones such as cortisol and dopamine and accelerate blood and lymphatic circulation, thereby improving the function of the gastrointestinal system [3,21,22,26-29]. Many studies [24,25,29-32], especially those conducted in China, have explored pediatric Tui na as a treatment for FI in premature infants. However, the results of these studies are inconsistent. For instance, several investigations [24,25,30] have indicated that pediatric Tui na provides significant benefits to premature infants with FI, including improved weight gain; reduced time to achieve full enteral feeding; reduction in GRV, emesis, and abdominal distention; and a notable reduction in the average length of hospital stay. However, Liu and Zhang [31] did not find any significant difference between the control group and the pediatric Tui na group in terms of weight gain or the time required to return to birth weight (P>.05). Additionally, a meta-analysis [33] suggested that massage benefits premature infants with FI. However, this analysis was limited to studies published in Persian and English. Furthermore, it primarily evaluated the effects of massage on GRV and did not specifically address the efficacy and safety of pediatric Tui na regarding intestinal function and other FI-associated factors in premature infants. Therefore, despite the research mentioned above, to our knowledge, no studies have specifically addressed the safety and efficacy of pediatric Tui na in premature infants with FI, highlighting a gap in understanding its role as a nonpharmacological treatment for these infants. Moreover, no published systematic review, meta-analysis, or review protocol focusing on TCM-based pediatric Tui na for premature infants with FI is yet available.

    Considering the high heterogeneity of previous studies and their varying outcomes, as well as the absence of any comprehensive evidence on this subject, it is crucial to assess the effectiveness and safety of pediatric Tui na for premature infants with FI. We intend to conduct a systematic review and meta-analysis to enhance the current evidence base on the effectiveness of pediatric Tui na for FI in premature infants. To ensure the most comprehensive data collection, minimize publication bias, and summarize the currently available evidence, we will conduct electronic searches for studies published both in English and Chinese.


    Overview

    The protocol for this review has been registered with the National Institute for Health Research (PROSPERO 2023 CRD42023390021) [34]. This protocol will be reported and conducted according to the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Extension for Protocols) 2015 guidelines [35] and the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) guidelines [36].

    Study Selection Criteria

    The eligibility criteria of studies will be presented in the PICOS (Patient, Intervention, Comparison, Outcome, and Study) design framework [37,38].

    Types of Studies

    The following types of studies will be included: (1) any nonrandomized clinical studies, nonrandomized controlled trials, randomized controlled trials, and quasi-experimental studies, wherein the treatment group involved premature infants with FI who received pediatric Tui na; (2) interventional studies, retrospective or prospective observational studies, or case series; and (3) studies that reported and included data associated with specific primary (NEC, GRV, emesis, abdominal distension, and stool) and secondary outcomes (weight gain, time to achieve full enteral feeding, length of hospital stay, and any AEs associated with pediatric Tui na). Single-case reports will not be included.

    Participants

    On the basis of any definition of FI, we included studies in which premature infants received pediatric Tui na to prevent or treat FI. We will identify prematurely born infants as per the definition of the World Health Organization (WHO); this includes infants born within 259 days from the first date of the mother’s last menstrual period or before 37 full weeks of gestation [39].

    Intervention

    We will include all trials evaluating pediatric Tui na intervention for FI.

    Comparison

    We will include studies with different control interventions, such as placebo and other currently used interventions (eg, physiotherapy, acupuncture, gentle touch, and medication), and those without any control group.

    Outcomes

    Emesis, NEC, GRV, and stool blood will be included as primary outcomes. Any AEs associated with pediatric Tui na, abdominal distension, time to achieve full enteral feeding, length of hospital stay, and weight gain will be included as secondary outcomes.

    Search Strategy

    A comprehensive search will be performed in the following databases: Springer, Cochrane Library, Embase, MEDLINE, Clarivate Analytics, Physiotherapy Evidence Database (PEDro), CINAHL, PubMed, Scopus, WHO International Clinical Trials Registry Platform, and Chinese biomedical databases (Wanfang database, the China National Knowledge Infrastructure, Chinese Scientific Journals Database, and Chinese Biomedical Literature Databases), limited to studies published in Chinese and English languages between January 2000 and January 2023. The database searches will include only studies published in peer-reviewed journals and reporting results within their full text. Experts will be consulted for including additional studies. With inputs from the principal investigator of the study, an experienced librarian at Nanjing University of Chinese Medicine will design and carry out a comprehensive literature search. For searching publications on the safety and effect of pediatric Tui na on premature infants with FI, we will use controlled vocabulary and keywords. Table 1 shows the search strategy for the PubMed database.

    Table 1. Search strategy for the PubMed database.
    NumberSearch terms
    1Feeding intolerance [MeSHa]
    2(Feeding intolerance OR feeding difficulties OR gastrointestinal motility OR gastroesophageal reflux OR gastric residuals, abdominal distension, OR emesis): ti, abb
    31 OR 2
    4Tui na therapy [MeSH]
    5(Tui na OR pediatric Tui na OR massage OR tactile-kinesthetic stimulation OR massaging OR massotherapy OR manipulation OR chiropractic therapy OR abdominal Tui na therapy OR spinal manipulation OR Tui na using a single thumb): ti, ab
    64 OR 5
    7Randomised: ti, ab
    8Randomized: ti, ab
    9Randomly: ti, ab
    10Clinical trials [MeSH]
    11Trial: ti, ab
    12Randomized controlled trial [MeSH]: ti, ab
    13Randomized controlled trial [MeSH]: ti, ab
    14Controlled trial [MeSH]: ti, ab
    157 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14
    16Premature infants
    1715 AND 16
    183 AND 6 AND 17

    aMeSH: Medical Subject Headings.

    bti, ab: terms in either title or abstract fields.

    Study Selection

    The retrieved literature will be imported into Endnote X9 (Clarivate Analytics); duplicate literature will be removed. A total of 2 authors will independently screen the titles and abstracts. Studies not meeting the inclusion criteria will be excluded. To seek full-text copies of studies or clarification of methods or results, study authors will be contacted through email if required. The latest or most comprehensive literature information will be extracted if multiple articles report the findings of the same study. Figure 1 shows the flow diagram for study selection.

    ‎
    Figure 1. Flow diagram for study selection.

    Methodological Quality and Risk of Bias Appraisal

    A total of 2 researchers will evaluate the quality of the literature using the quality evaluation method of the Cochrane Collaboration System evaluator manual on the following 6 aspects [40]: concealment of the allocation scheme, generation of a random allocation scheme, complete data results, selective reporting results, blinding method, and other risks of bias.

    Data Extraction

    A total of 2 independent reviewers will extract information using a predesigned form after identifying the studies to be included. The form will include data on the following aspects:

    1. Identification information (first author, publication year, study design, country, and setting)
    2. General information (study type, country, sample size, number of centers, and study design)
    3. Participants (weight, sex, and age of premature infants)
    4. Interventions (pediatric Tui na, type of pediatric Tui na, pediatric Tui na technique, pediatric Tui na position selection, and frequency and duration of sessions)
    5. Comparator (if available, treatment details, including dosage, name, course, and frequency)
    6. Outcomes (safety, efficacy data, and time points for each measurement)

    If any information is missing or there is a need to seek further clarification, we will attempt to contact the corresponding authors.

    Assessment of Reporting Bias

    We will use funnel plots to detect publication bias in the overall estimate and Egger and Begg tests to examine the funnel plot asymmetry. Symmetry and asymmetry in the funnel plot indicate low and high risks of reporting bias, respectively.

    Data Synthesis

    Meta-analyses or descriptive analyses will be performed as per the measurement results, heterogeneity levels, and intervention measures. Conversely, we will report quantitative research results descriptively. Continuous variables will be analyzed according to mean differences and 95% CIs. Dichotomous variables will be assessed using risk ratios. Standardized mean differences and 95% CIs will be calculated if the outcome measure scales differ. Heterogeneity assessments will be performed within each pairwise comparison by the Cochran Q test and the I2 statistic. Negative I2 values will be treated as 0%, indicating no heterogeneity. I2<50% indicates low heterogeneity, while I2≥50% indicates high heterogeneity [41]. For sensitivity analysis, the results will be compared with those of other meta-analysis models, which would exclude trials with a high risk of bias and include fixed-effects models. We will perform a meta-analysis using a random-effects model if at least two included trials are found to be sufficiently homogeneous for the aspects of the comparator, outcome measurement, and study design. For performing the meta-analysis, the Cochrane Collaboration’s software Review Manager (version 5.4) will be used. Subgroup analyses will be considered according to the treatment received, country or setting, sex, and birth weight of premature infants (if heterogeneity is high, I2≥50%).

    Dissemination

    This meta-analysis and systematic review will be submitted to a peer-reviewed journal. The findings are expected to shed some light on the efficacy and safety of pediatric Tui na for premature infants with FI.


    This is a systematic review and meta-analysis protocol, so the results are not yet available. This protocol has been registered with PROSPERO (CRD42023390021) on February 8, 2023 [34]. We are currently in the study selection phase. Results are expected to be completed by the end of 2023.


    This study aims to conduct a systematic review and meta-analysis of relevant research articles to comprehensively summarize the current evidence regarding the efficacy of pediatric Tui na for premature infants with FI. Pediatric Tui na, originated in China over 2300 years ago, was first recorded in Wushierbingfang (Prescriptions for Fifty-two Diseases) [42]. It is a commonly used, convenient, noninvasive, and cost-effective intervention therapy suitable for children [43]. Xie et al [44] reported that working on specific acupoints of the skin surface in pediatric Tui na can improve the gastrointestinal function of children. Xiao et al [24] and Chen [29] have reported that pediatric Tui na can accelerate gastrointestinal tract maturity, promote intestinal evacuation, and increase gastrointestinal motility in premature infants, thus alleviating FI. Although many clinical trials [24,25,30-32] have evaluated pediatric Tui na for treating FI in children, its efficacy and clinical evidence have not yet been established. The current clinical guidelines in China recommend massage therapy for treating FI in premature infants [17]. Despite being a TCM-based approach, pediatric Tui na is currently not included in the guidelines for treating FI in premature infants. This omission has prevented it from being widely and successfully adapted as a potential treatment for FI in premature infants. This study will be the first to evaluate the effect and safety of TCM-based pediatric Tui na for FI in premature infants by objectively synthesizing the currently available publications.

    Some limitations should be considered in this systematic review. First, it will consider only studies published in Chinese and English, which could introduce potential language bias, resource constraints, difficulty locating non-English studies, and the possibility of bias in data extraction and analysis. Second, the specific focus of our research question might restrict the number of eligible studies for inclusion in the proposed review. Nonetheless, our objective is to extract valuable insights from the available evidence to offer preliminary guidance for current FI practices and future research. To stay updated with new evidence, we plan to conduct updates to the systematic review and meta-analysis every 3 years.

    This protocol intends to aggregate current research, provide greater insights into the efficacy and safety of pediatric Tui na for FI, and offer a comprehensive assessment of the evidence for pediatric Tui na treatment of FI in premature infants for health care providers worldwide. Additionally, it will lay the groundwork for future research in pediatric Tui na and serve as a reference for the potential inclusion of pediatric Tui na in the treatment guidelines for premature infants with FI.

    Acknowledgments

    This study was supported and funded by the Youth Program of the National Natural Science Foundation of Nanjing University of Chinese Medicine (NZY81704138). We would like to extend our sincere gratitude to Yufeng Zhang, Youxin Sui, and Kaiyue Han for their invaluable contributions during the writing of this paper. Their expertise and insights greatly enhanced our work.

    Data Availability

    Data sharing is not applicable to this article as no data sets were generated or analyzed during this study.

    Authors' Contributions

    ZB and MW wrote the original draft of the manuscript. YT and XL curated the data. ZB and XL analyzed the data. YT reviewed and edited the manuscript. MW contributed to project administration and supervision.

    Conflicts of Interest

    None declared.

    1. Lucchini R, Bizzarri B, Giampietro S, De Curtis M. Feeding intolerance in preterm infants. How to understand the warning signs. J Matern Fetal Neonatal Med. 2011;24(Suppl 1):72-74. [FREE Full text] [CrossRef] [Medline]
    2. Chen Q, Fang JB, Peng WT. [Risk prediction of feeding intolerance in preterm infants]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2016;47(5):749-754. [Medline]
    3. Huang X, Chen Q, Peng W. [Clinical characteristics and risk factors for feeding intolerance in preterm infants]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(7):797-804. [FREE Full text] [CrossRef] [Medline]
    4. Tekgündüz KS, Gürol A, Apay SE, Caner I. Effect of abdomen massage for prevention of feeding intolerance in preterm infants. Ital J Pediatr. 2014;40:89. [FREE Full text] [CrossRef] [Medline]
    5. Fanaro S. Strategies to improve feeding tolerance in preterm infants. J Matern Fetal Neonatal Med. 2012;25(Suppl 4):54-56. [CrossRef] [Medline]
    6. Chi C, Buys N, Li C, Sun J, Yin C. Effects of prebiotics on sepsis, necrotizing enterocolitis, mortality, feeding intolerance, time to full enteral feeding, length of hospital stay, and stool frequency in preterm infants: a meta-analysis. Eur J Clin Nutr. 2019;73(5):657-670. [FREE Full text] [CrossRef] [Medline]
    7. Weeks CL, Marino LV, Johnson MJ. A systematic review of the definitions and prevalence of feeding intolerance in preterm infants. Clin Nutr. 2021;40(11):5576-5586. [FREE Full text] [CrossRef] [Medline]
    8. Li H, Li B, Wen X. Clinical efficacy of phentolamine in the treatment of feeding intolerance in premature infants with low birth weight. Pak J Med Sci. 2020;36(7):1655-1658. [FREE Full text] [CrossRef] [Medline]
    9. Kairamkonda VR, Deorukhkar A, Bruce C, Coombs R, Fraser R, Mayer APT. Amylin peptide is increased in preterm neonates with feed intolerance. Arch Dis Child Fetal Neonatal Ed. 2008;93(4):F265-F270. [FREE Full text] [CrossRef] [Medline]
    10. Fanaro S. Feeding intolerance in the preterm infant. Early Hum Dev. 2013;89(Suppl 2):S13-S20. [FREE Full text] [CrossRef] [Medline]
    11. Nguyen NQ. Pharmacological therapy of feed intolerance in the critically ills. World J Gastrointest Pharmacol Ther. 2014;5(3):148-155. [FREE Full text] [CrossRef] [Medline]
    12. Ng E, Shah VS. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database Syst Rev. 2008(3):CD001815. [FREE Full text] [CrossRef] [Medline]
    13. Dutta S, Singh B, Chessell L, Wilson J, Janes M, McDonald K, et al. Guidelines for feeding very low birth weight infants. Nutrients. 2015;7(1):423-442. [FREE Full text] [CrossRef] [Medline]
    14. Ward RM, Lemons JA, Molteni RA. Cisapride: a survey of the frequency of use and adverse events in premature newborns. Pediatrics. 1999;103(2):469-472. [FREE Full text] [CrossRef] [Medline]
    15. Eras Z, Oğuz SS, Dilmen U. Is metoclopramide safe for the premature infant? Eur Rev Med Pharmacol Sci. 2013;17(12):1655-1657. [FREE Full text] [Medline]
    16. Anabrees J, Shah VS, Alosaimi A, Alfaleh K. Glycerin laxatives for prevention or treatment of feeding intolerance in very low birth weight infants. Cochrane Database Syst Rev. 2015;2015(9):CD010464. [FREE Full text] [CrossRef] [Medline]
    17. Evidence-Based Medicine Group; Neonatologist Society; Chinese Medical Doctor Association. [Clinical guidelines for the diagnosis and treatment of feeding intolerance in preterm infants (2020)]. Zhongguo Dang Dai Er Ke Za Zhi. 2020;22(10):1047-1055. [FREE Full text] [CrossRef] [Medline]
    18. Benchmarks for training in traditional / complementary and alternative medicine: benchmarks for training in naturopathy. World Health Organization. 2010. URL: https://www.who.int/publications/i/item/9789241599658 [accessed 2023-09-14]
    19. Zhang X, Hu L, Li L, Wang Y, Zhang C, Su J, et al. Pediatric Tuina for functional constipation in children: study protocol for a randomized controlled trail. Trials. 2022;23(1):750. [FREE Full text] [CrossRef] [Medline]
    20. Moyer CA, Rounds J, Hannum JW. A meta-analysis of massage therapy research. Psychol Bull. 2004;130(1):3-18. [CrossRef] [Medline]
    21. Lu T, Yin L, Chen R, Zhang H, Cai J, Li M, et al. Chinese pediatric Tuina on children with acute diarrhea: a randomized sham-controlled trial. Health Qual Life Outcomes. Jan 06, 2021;19(1):4. [FREE Full text] [CrossRef] [Medline]
    22. Chen SC, Cheng HL, Han LF, Wu GT, Zhang RY, Suen LKP, et al. Parent-administered pediatric tuina for the treatment of attention deficit hyperactivity disorder symptoms: process evaluation of a pilot randomized controlled trial. Complement Ther Med. 2022;70:102854. [FREE Full text] [CrossRef] [Medline]
    23. Chen SC, Cheng HL, Wang DD, Wang S, Yin YH, Suen LKP, et al. Experience of parents in delivering pediatric tuina to children with symptoms of attention deficit hyperactivity disorder during the COVID-19 pandemic: qualitative findings from focus group interviews. BMC Complement Med Ther. 2023;23(1):53. [FREE Full text] [CrossRef] [Medline]
    24. Xiao J, Zhang X, Cai W. Clinical observation of pediatric Tui na treatment for premature infants with feeding intolerance. China's Naturopathy. 2020;28(24):50-52. [FREE Full text] [CrossRef]
    25. Zhang Y. Clinical observation on 48 cases of feeding intolerance in premature infants treated by pediatric Tui na as adjunctive therapy. J Pediatr Tradit Chin Med. 2021;17(02):83-86. [FREE Full text]
    26. Field T, Hernandez-Reif M, Diego M, Schanberg S, Kuhn C. Cortisol decreases and serotonin and dopamine increase following massage therapy. Int J Neurosci. 2005;115(10):1397-1413. [FREE Full text] [CrossRef] [Medline]
    27. Field T, Diego M, Hernandez-Reif M, Dieter JNI, Kumar AM, Schanberg S, et al. Insulin and insulin-like growth factor-1 increased in preterm neonates following massage therapy. J Dev Behav Pediatr. 2008;29(6):463-466. [FREE Full text] [CrossRef] [Medline]
    28. Lindgren L, Rundgren S, Winsö O, Lehtipalo S, Wiklund U, Karlsson M, et al. Physiological responses to touch massage in healthy volunteers. Auton Neurosci. 2010;158(1-2):105-110. [FREE Full text] [CrossRef] [Medline]
    29. Chen Y. The application of pediatric Tui na in the early intervention of feeding intolerance in premature infants. Mod Diagn Treat. 2015;26(05):1093-1094. [FREE Full text]
    30. Hu S. Clinical observation on 35 cases of feeding intolerance in premature infants treated with pediatric Tui na. J Pediatr Tradit Chin Med. 2018;14(03):70-73. [FREE Full text]
    31. Liu H, Zhang S. Effectiveness of acupressure combined with oral exercise intervention to prevent feeding intolerance in premature infants. Mod Med J China. 2021;23(05):91-94. [FREE Full text]
    32. Li SS, Lin XY, Li X, Zhang YD, Wang LQ, Lai S. Chinese pediatric Tuina can prevent premature infant feeding intolerance and is conducive to weight gain: a prospective randomized controlled study. Afr Health Sci. 2023;23(2):703-708. [FREE Full text] [CrossRef]
    33. Seiiedi-Biarag L, Mirghafourvand M. The effect of massage on feeding intolerance in preterm infants: a systematic review and meta-analysis study. Ital J Pediatr. 2020;46(1):52. [FREE Full text] [CrossRef] [Medline]
    34. Wang M, Bai Z, Lyu X, Tang Y. Pediatric Tui na for feeding intolerance in premature infants: Protocol for a systematic review and meta-analysis. National Institute for Health and Care Research. 2023. URL: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023390021 [accessed 2023-02-07]
    35. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. [FREE Full text] [CrossRef] [Medline]
    36. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-341. [FREE Full text] [CrossRef] [Medline]
    37. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. [FREE Full text] [CrossRef] [Medline]
    38. Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11(1):15. [FREE Full text] [CrossRef] [Medline]
    39. Ren Q, Wan B, Luo X, Liu Q, Gong H, Li H, et al. Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. Eur Radiol. 2023;33(6):4214-4222. [FREE Full text] [CrossRef] [Medline]
    40. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Cochrane Bias Methods Group; et al. Cochrane Statistical Methods Group. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. [FREE Full text] [CrossRef] [Medline]
    41. Melsen WG, Bootsma MCG, Rovers MM, Bonten MJM. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014;20(2):123-129. [FREE Full text] [CrossRef] [Medline]
    42. Li K, Xiang J. Effect of pediatric massage on feeding intolerance of premature infants. China Foreign Med Treat. 2020;39(17):88-91. [FREE Full text]
    43. Liu M, Wang J. In: Liu M, Wang J, editors. Pediatric Massage. China. China Press of Traditional Chinese Medicine; 2016.
    44. Xie T, Jiang H, Zhang C. Clinical observation of pediatric Tuina plus oral Chinese medication for pediatric anorexia due to spleen failing in transportation. J Acupunct Tuina Sci. 2022;20(2):119-125. [FREE Full text] [CrossRef]

    ‎
    AE: adverse effect
    FI: feeding intolerance
    GRV: gastric residual volume
    NEC: necrotizing enterocolitis
    PEDro: Physiotherapy Evidence Database
    PICOS: Patient, Intervention, Comparison, Outcome, and Study
    PRISMA: Preferred Reporting Items for Systematic Review and Meta-Analysis
    PRISMA-P: Preferred Reporting Items for Systematic Review and Meta-Analysis Extension for Protocols
    TCM: traditional Chinese medicine
    WHO: World Health Organization

    Edited by A Mavragani; submitted 09.02.23; peer-reviewed by C Lau, S Chalise; comments to author 31.05.23; revised version received 24.08.23; accepted 08.09.23; published 16.10.23.

    Copyright

    ©Zirong Bai, Xiaoxiao Lyu, Yichuan Tang, Meng Wang. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 16.10.2023.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.